Roivant Sciences (ROIV) EBT Margin (2020 - 2025)
Historic EBT Margin for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to 14525.71%.
- Roivant Sciences' EBT Margin fell 119252100.0% to 14525.71% in Q4 2025 from the same period last year, while for Dec 2025 it was 16606.06%, marking a year-over-year decrease of 383675000.0%. This contributed to the annual value of 2346.02% for FY2025, which is 163094500.0% down from last year.
- As of Q4 2025, Roivant Sciences' EBT Margin stood at 14525.71%, which was down 119252100.0% from 10123.74% recorded in Q3 2025.
- Roivant Sciences' 5-year EBT Margin high stood at 33116.21% for Q4 2023, and its period low was 14525.71% during Q4 2025.
- Its 5-year average for EBT Margin is 2462.91%, with a median of 2503.44% in 2022.
- Per our database at Business Quant, Roivant Sciences' EBT Margin skyrocketed by 353568700bps in 2023 and then plummeted by -357167100bps in 2024.
- Quarter analysis of 5 years shows Roivant Sciences' EBT Margin stood at 1257.33% in 2021, then crashed by -78bps to 2240.66% in 2022, then surged by 1578bps to 33116.21% in 2023, then tumbled by -108bps to 2600.5% in 2024, then plummeted by -459bps to 14525.71% in 2025.
- Its EBT Margin stands at 14525.71% for Q4 2025, versus 10123.74% for Q3 2025 and 12408.39% for Q2 2025.